COSMOS Pharmaceutical Corporation Financial Overview
COSMOS Pharmaceutical Corporation's market cap is currently ¥629.40B. The company's EPS TTM is ¥103.1; its P/E ratio is 20.21; and it has a dividend yield of 0.94%. COSMOS Pharmaceutical Corporation is scheduled to report earnings on October 8, 2025, and the estimated EPS forecast is ¥84.01. See an overview of income statement, balance sheet, and cash flow financials.
